Barclays BCS shares have soared 68.4% so far this year, outperforming the industry’s growth of 45.5%. Moreover, the company ...

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the most promising stocks with huge upside potential. On November 24, ...

A new Barclays Impact Series report explores the global race for pre-eminence in Artificial Intelligence – and the strains on resources, and likely geostrategic tensions, that will result. AI ...

‘Hubs’ bring key market themes into focus, delivering cross-asset expert opinions, Signature reports, events and data - all in one streamlined location. From Deepseek to Tariffs 2.0, Hubs illuminate ...

Barclays PLC's Q4 results showed a 24.3% increase in total income, driven by strong performance in UK and Investment Banking, despite a 4% ADR drop. Concerns arise from Barclays UK's credit headwinds, ...

Barclays remains undervalued despite an 80% rally, with strong profitability, cost control, and management focused on shareholder returns. The bank's diversified business mix, international reach, and ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. Barclays said in February that it was exploring a sale or ...

Barclays PLC closed 0.22% below its 52-week high of £4.31, which the company achieved on November 13th.